Optimize Percutaneous Coronary Intervention with a Scoring Balloon Webinar
Release time:
2021-05-11
Guangdong [May 11 , 2021] – Brosmed Medical Ltd. hosted its first global webinar: Optimize Percutaneous Coronary Intervention with a Scoring Balloon on April 27th 2021. This webinar was hosted by Prof. Stephane Carlier from Belgium together with Dr. Bernardo Cortese from Italy and Prof. Jo Dens from Hart Center Genk in Belgium.
Guangdong [May 11 , 2021] – Brosmed Medical Ltd. hosted its first global webinar: Optimize Percutaneous Coronary Intervention with a Scoring Balloon on April 27th 2021. This webinar was hosted by Prof. Stephane Carlier from Belgium together with Dr. Bernardo Cortese from Italy and Prof. Jo Dens from Hart Center Genk in Belgium.
Prof. Carlier´s presented the currently ongoing ¨Wedges¨ trial, a prospective, multi-center randomized trial for the evaluation of coronary lesion preparation With Enhanced Dilatation for Good Expansion of Stent: assessment of a new scoring balloon by quantitative stent enhanced visualization. Prof. Carlier also presented several case studies and a literature review showing the advantages of using a scoring balloon to optimize percutaneous coronary intervention (PCI).
Dr. Cortese presented several challenging cases that were facilitated with Brosmed´s Wedge scoring balloon and reviewed data gathered in a multi center Italian registry showing the advantages of using a scoring balloon to facilitate PCI.
Brosmed´s Wedge NC is a non-compliant high pressure balloon dilatation catheter which is designed to feel like a conventional balloon. With one fixed nitinol wire on top of the balloon surface, Wedge NC provides exact scoring and avoids twisted wired or interference with the stent.
Prof. Dr. Jo Dens shared his experience with the Wedge scoring balloon in calcified lesions and wrapped up the Webinar with an educational review of Tips and Tricks using the Wedge scoring balloon.
Brosmed Medical has a full range of products for PTCA as well as PTA and continues to support the global scientific community during the Covid pandemic.
About BrosMed Medical
BrosMed Medical develops, manufactures and markets medical devices primarily used by interventional cardiologists, radiologists and vascular surgeons in angioplasty procedures and other minimal invasive devices.
We provide solutions to our customers through innovative design, effective supply chain management, world-class manufacturing, and flexible channels of distribution and through the development or acquisition of innovative technologies.
Learn more about Brosmed at http://www.brosmed.com
Join with Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announced CE MDR Approval of New Generation Conger™ Plus Hydrophilic Guidewires
Designed for superior crossability and maneuverability in peripheral interventions, Conger Plus now offers 116 models with expanded sizes (OD 0.018'' to 0.038'') and lengths (up to 300cm).
2025-04-25
Meet BrosMed at ESC Congress 2024
BrosMed Medical is delighted to participate in the ESC Congress 2024 from August 30th to September 2nd in London, UK.
2024-08-15
BrosMed Medical Announces Scott J. Addonizio as Chief Operating Officer
2024 August 1st – BrosMed Medical is pleased to announce the appointment of Scott J. Addonizio as its Chief Operating Officer (COO), effective immediately. Mr. Scott J. Addonizio brings a wealth of experience and expertise to BrosMed, with a distinguished career spanning almost 30 years in the medical device industry. Prior to joining BrosMed, Mr. Addonizio served as SVP at Cordis and COO at MedAlliance Swiss Medical Technology.
2024-08-01
CTO&CHIP PCI – Insights from the clinical practice (Ⅱ)
July 30, 2024 @16:00-17:30 (Beijing Time) Join BrosMed Medical on Tuesday, July 30 for an enlightening discussion that unites cardiologists from Malaysia, China, India, Tunisia and Portugal, where clinical expertise harmoniously fuses with CTO&CHIP innovation. At this exclusive webinar, we’re orchestrating a confluence of valuable insights, drawing from the collective wisdom of seasoned interventional cardiologists.
2024-07-26
BrosMed Announced CE MDR Approval of New Generation PTA SC Balloon Dilatation Catheters
May 27, 2024- BrosMed announced that it receives European Medical Device Regulation (MDR) certification for the New Generation PTA SC Balloon Dilatation Catheters (Brand Name: Polux™ Pro 014, Minerva™ Pro 018 and Atropos™ Pro 035).
2024-05-27